China is likely to seek more concessions from drugmakers

04/9/2013 | Bloomberg

The Chinese government is likely to seek pricing concessions from drugmakers on expensive cancer medicines and might resort to compulsory licensing in some cases, former health minister Chen Zhu said. Annual spending on health care in China is expected to reach $1 trillion by 2020, according to a McKinsey & Co. analysis.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA